154 related articles for article (PubMed ID: 29027288)
1. CXXC5 expression in prostate cancer: implications for cancer progression.
Benedetti I; De Marzo AM; Geliebter J; Reyes N
Int J Exp Pathol; 2017 Aug; 98(4):234-243. PubMed ID: 29027288
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
4. Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue.
Bründl J; Wallinger S; Breyer J; Weber F; Evert M; Georgopoulos NT; Rosenhammer B; Burger M; Otto W; Rubenwolf P
BMC Urol; 2018 Sep; 18(1):75. PubMed ID: 30176851
[TBL] [Abstract][Full Text] [Related]
5. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
6. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
9. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ
Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950
[TBL] [Abstract][Full Text] [Related]
10. Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer.
Zhong C; Yang S; Huang J; Cohen MB; Roy-Burman P
Cancer Biol Ther; 2003; 2(2):179-84. PubMed ID: 12750559
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
12. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.
Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
Histopathology; 2007 Apr; 50(5):648-58. PubMed ID: 17394502
[TBL] [Abstract][Full Text] [Related]
13. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
14. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.
Gu K; Mes-Masson AM; Gauthier J; Saad F
Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823
[TBL] [Abstract][Full Text] [Related]
16. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
Wang W; Bergh A; Damber JE
APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
[TBL] [Abstract][Full Text] [Related]
17. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
Ruiz M; Troncoso P; Bruns C; Bar-Eli M
Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
[TBL] [Abstract][Full Text] [Related]
18. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal.
Walensky LD; Coffey DS; Chen TH; Wu TC; Pasternack GR
Cancer Res; 1993 Oct; 53(19):4720-6. PubMed ID: 7691403
[TBL] [Abstract][Full Text] [Related]
19. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
20. The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue.
Reyes N; Benedetti I; Bettin A; Rebollo J; Geliebter J
Cancer Biomark; 2016; 16(1):191-202. PubMed ID: 26600400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
